InVivo Therapeutics Holdings Overview

InVivo Therapeutics Holdings Gross Profit

Gross Profit analysis for NVIV.

Quarterly Gross Profit

$-72000.00

↓ 34.55% YoY

As of Sep 30, 2023

Annual Gross Profit (TTM)

$-420000.00

↑ 281.82% YoY

Trailing 12 months ending Sep 30, 2023

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin